written on 12.05.2014
Tags:
,

Overcoming Clinical Challenges in Brazil

TAGS: ,

In 2012, Brazil ranked sixth in pharmaceutical spending. By 2017, IMS predicts that the country will rise to fourth, just behind Japan. Ideally, performing clinical trials in Brazil averages a cost savings of 20 to 30 percent as compared to Western markets. Though Brazil boasts a national healthcare program, the Unified Health System (SUS), it […]

Latest Report